Abstract
Introduction/BackgroundIn advanced epithelial ovarian cancer (AEOC) patients with unresectable disease in initial presentation neoadjuvant chemotherapy followed by interval cytoreduction is beneficial in improving patient survival. Cytoreductive surgery including extensive upper...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have